Baxter International Inc. NYQ · BAX
Price alert —
Sign in to get a one-time email the moment BAX crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · BAX
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.7B | $-0.0B | $0.1B | $0.1B | -0.6% | 2.4% |
| 2025-12-31 | $3.0B | $-1.1B | $-0.2B | $0.4B | -37.9% | -8.2% |
| 2025-09-30 | $2.8B | $-0.0B | $0.2B | $0.1B | -1.6% | 6.1% |
| 2025-06-30 | $2.8B | $0.1B | $0.2B | $0.1B | 3.2% | 6.8% |
| 2025-03-31 | $2.6B | $0.1B | $0.1B | $-0.3B | 4.8% | 2.2% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare BAX vs peers
Line BAX up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with BAX
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-04-30 | 0.36 | 0.31 | +15.9% | -2.1% |
| 2026-02-12 | 0.44 | 0.54 | -17.8% | +5.8% |
| 2025-10-30 | 0.69 | 0.60 | +15.4% | -3.6% |
| 2025-07-31 | 0.59 | 0.61 | -3.3% | +0.9% |
| 2025-05-01 | 0.55 | 0.48 | +13.8% | +0.1% |
| 2025-02-20 | 0.58 | 0.53 | +9.6% | +1.1% |
| 2024-11-08 | 0.80 | 0.78 | +3.0% | -1.2% |
| 2024-08-06 | 0.68 | 0.66 | +2.7% | -0.9% |
| 2024-05-02 | 0.65 | 0.61 | +7.2% | -0.1% |
| 2024-02-08 | 0.88 | 0.86 | +1.8% | -2.2% |
| 2023-11-02 | 0.68 | 0.68 | +0.3% | -0.8% |
| 2023-07-27 | 0.55 | 0.60 | -8.3% | +3.4% |
| 2023-04-27 | 0.59 | 0.49 | +19.6% | +1.9% |
| 2023-02-09 | 0.88 | 0.94 | -6.1% | +2.0% |
| 2022-10-27 | 0.82 | 0.81 | +0.7% | +1.9% |
| 2022-07-28 | 0.87 | 0.87 | -0.3% | -1.4% |
| 2022-04-28 | 0.93 | 0.81 | +15.5% | +0.4% |
| 2022-02-17 | 1.04 | 1.03 | +1.1% | -0.5% |
| 2021-10-28 | 1.02 | 0.94 | +8.8% | +0.5% |
| 2021-07-29 | 0.80 | 0.75 | +6.9% | -0.0% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| BAX ★ | $12B | — | 11.3 | 1.0 | 10.1 | 1.9 | 34.6% | 2.9% | — | 7.71% |
| LLY | — | 41.8 | 26.3 | — | 30.1 | — | 82.8% | 55.5% | 169.9% | — |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | — | 36.0 | 13.2 | — | 12.1 | 6.9 | 76.7% | 4.9% | — | — |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | — | 19.1 | 8.8 | — | 7.6 | — | 74.8% | 5.4% | -10.1% | — |
| TMO | — | 29.2 | 19.5 | — | 21.1 | — | 40.9% | 6.2% | 11.3% | — |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 70.89%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 79,400,664 | 15.37% |
| Pzena Investment Management LLC | 64,527,823 | 12.49% |
| Dodge & Cox Inc. | 57,254,570 | 11.09% |
| FMR, LLC | 46,264,804 | 8.96% |
| Vanguard Capital Management LLC | 33,506,975 | 6.49% |
| Vanguard Portfolio Management LLC | 23,993,355 | 4.65% |
| State Street Corporation | 19,979,957 | 3.87% |
| Greenhaven Associates, Inc. | 14,307,688 | 2.77% |
| Geode Capital Management, LLC | 13,762,965 | 2.66% |
| Invesco Ltd. | 13,121,171 | 2.54% |
Insider activity · 90d
9 buys / 0 sells · ratio 9.0 · Finnhub
- Wallace Steven P. F 70,128 @ $18.68
- Teaff James F 31,063 @ $18.68
- Zielinski Anita A BUY 59,714
- Wilkes David S. BUY 37,076
- Wendell Amy McBride BUY 44,235
- Shafer David Brent BUY 72,804
- McDonnell Michael R. BUY 14,647
- Craig Jeffrey A BUY 23,662
- Ampofo William A. II BUY 30,375
- SCHLICHTING NANCY M BUY 34,994
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 8-K | 2026-07-14 | 8-K | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 4 | 2026-06-03 | FORM 4 | view · |
| 8-K | 2026-05-08 | 8-K | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 10-Q | 2026-04-30 | 10-Q | view · |
| 8-K | 2026-04-30 | 8-K | view · |
| DEF 14A | 2026-03-23 | DEF 14A | view · |
| 8-K | 2026-03-19 | 8-K | view · |
| 8-K | 2026-03-16 | 8-K | view · |
| 4 | 2026-03-10 | FORM 4 | view · |
| 4 | 2026-03-10 | FORM 4 | view · |
| 4 | 2026-03-10 | FORM 4 | view · |
| 4 | 2026-03-10 | FORM 4 | view · |
| 4 | 2026-03-10 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-03-03 | FORM 4 | view · |
| 4 | 2026-02-18 | FORM 4 | view · |
| 10-K | 2026-02-12 | 10-K | view · |
| 8-K | 2026-02-12 | 8-K | view · |
| 4 | 2026-02-11 | FORM 4 | view · |
| 4 | 2026-02-11 | FORM 4 | view · |
| 4 | 2026-02-11 | FORM 4 | view · |
| 4 | 2026-02-11 | FORM 4 | view · |
| 8-K | 2025-12-22 | 8-K | view · |
| 4 | 2025-12-16 | FORM 4 | view · |
| 8-K | 2025-12-04 | 8-K | view · |
| 4 | 2025-12-03 | FORM 4 | view · |
| 8-K | 2025-11-25 | 8-K | view · |
| 8-K | 2025-11-19 | 8-K | view · |
| 8-K | 2025-11-19 | 8-K | view · |
| 8-K | 2025-11-12 | 8-K | view · |
| 10-Q | 2025-11-04 | 10-Q | view · |
| 8-K | 2025-10-30 | 8-K | view · |
| 8-K | 2025-10-21 | 8-K | view · |
| 4 | 2025-09-04 | FORM 4 | view · |
| 4 | 2025-09-04 | FORM 4 | view · |
| 4 | 2025-09-04 | FORM 4 | view · |
| 4 | 2025-09-04 | FORM 4 | view · |
| 4 | 2025-08-21 | FORM 4 | view · |
| 10-Q | 2025-08-05 | 10-Q | view · |
| 8-K | 2025-07-31 | 8-K | view · |
| 8-K | 2025-07-07 | 8-K | view · |
| 8-K | 2025-06-12 | 8-K | view · |
| 4 | 2025-06-04 | FORM 4 | view · |
| 4 | 2025-05-08 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
| 4 | 2025-05-08 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | view · |
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate s…
Options picks · BAX
ITM + OTM ideas from the latest scanLoading…
Congress trades · BAX
STOCK Act disclosuresLoading…
SEC filings & insiders · BAX
EDGAR · liveLoading…
Holders · BAX
Institutions & insider activityLoading…